Truist initiated coverage of Apollo Medical with a Hold rating and $41 price target. The analyst likes the company’s recent strategic initiatives, but awaits clarity and proof points around its expansion opportunities outside of California and its performance expanding towards full risk from partial risk.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMEH:
- Apollo Medical management to meet with BTIG
- Apollo Medical to acquire assets of Community Family Care Medical Group IPA
- Apollo Medical narrows FY23 EPS view to $1.10-$1.20 from $95c-$1.20
- Apollo Medical reports Q3 EPS 47c, consensus 33c
- Apollo Medical Holdings, Inc. Reports Third Quarter 2023 Results
